Clinical Trial

Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia

Study acronym: ALOE-DUTA-BPH
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a double blinded RCT with pre-post test design on the effect of combination of dutasteride and aloe vera, compared to dutasteride only, on uroflowmetry results, prostate volume, and VEGF serum level among patients with benign prostate hyperplasia. The treatment was given for 12 weeks
Trial Details
NCT Number NCT07065682
Lead Sponsor Universitas Diponegoro
Conditions BPH (Benign Prostatic Hyperplasia)
Enrollment 84 participants
Start Date 2023-07-01
Primary Completion 2024-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-15